NASDAQ:AVTX | Revenue | Avalo Therapeutics, Inc.

Complete source-backed revenue history.

Available history
2015-12-31 to 2025-12-31
Data captured

Historical Revenue

DateRevenue
2025-12-31$59,000.00
2025-09-30$0.00
2024-12-31$192,000.00
2024-09-30$249,000.00
2024-06-30$0.00
2024-03-31$0.00
2023-12-31$571,000.00
2023-09-30$236,000.00
2023-06-30$643,000.00
2023-03-31$475,000.00
2022-12-31$896,000.00
2022-09-30$14.95M
2022-06-30$1.03M
2022-03-31$1.17M
2021-12-31$219,000.00
2021-09-30$1.35M
2021-06-30$3.36M
2021-03-31$473,000.00
2020-12-31$1.5M
2020-09-30$1.11M
2020-06-30$1.34M
2020-03-31$2.75M
2019-12-31$580,808.00
2019-09-30$2.2M
2019-06-30$1.39M
2019-03-31$2.58M
2018-12-31-$6.31M
2018-09-30$4.07M
2018-06-30$4.79M
2018-03-31$4.48M
2017-12-31$2.23M
2017-09-30$25.04M
2017-06-30$157,800.00
2017-03-31$384.00
2016-12-31$181,002.00
2016-09-30$321,497.00

Annual Revenue

DateRevenue
2025-12-31$59,000.00
2024-12-31$441,000.00
2023-12-31$1.92M
2022-12-31$18.05M
2021-12-31$5.4M
2020-12-31$6.7M
2019-12-31$6.75M
2018-12-31$7.03M
2017-12-31$27.81M
2016-12-31$1.15M
2015-12-31$0.00